Best 10 tulathromycin Manufacturers in the world 2025

Dec 11, 2025

Leave a message

James Thomas
James Thomas
James is involved in the company's international trade business. He is familiar with international trade regulations and market trends, helping the company to expand its overseas market and promote cross - border cooperation.

Introduction to Tulathromycin

Tulathromycin is a semisynthetic macrolide antibiotic that has been widely used in veterinary medicine. It belongs to the azalide subclass of macrolides. Tulathromycin has a broad - spectrum antibacterial activity against many Gram - positive and some Gram - negative bacteria commonly found in livestock and poultry. It is particularly effective against pathogens such as Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis, which are major causes of respiratory diseases in cattle and swine. Its unique pharmacokinetic properties, including high tissue penetration, long half - life, and low minimum inhibitory concentration, make it a popular choice for the prevention and treatment of respiratory infections in animals, helping to improve animal health and productivity in the livestock industry.


1. Shandong High Chem - Pharm Co., Ltd.

Company Introduction

Shandong High Chem - Pharm Co., Ltd. is a leading pharmaceutical company based in Shandong, China. The company is committed to the research, development, production, and sales of high - quality veterinary drugs. With a modern production base and advanced manufacturing equipment, it adheres to strict quality control systems in line with international standards. The company has a professional R & D team composed of experienced pharmacists, chemists, and veterinarians, who are constantly exploring new drug formulations and improving the quality of existing products.


In addition to its focus on product quality, Shandong High Chem - Pharm Co., Ltd. also attaches great importance to environmental protection and sustainable development in its production processes. It has established long - term partnerships with many domestic and international distributors, and its products are well - received in the global market.


Tulathromycin - related Features and Company Advantages

  • Quality Assurance: The company strictly controls the production process of tulathromycin from raw material sourcing to finished product packaging. It uses high - purity raw materials and advanced purification techniques to ensure the high quality and stability of the product. The tulathromycin produced meets the strictest international quality standards, such as European Pharmacopoeia and United States Pharmacopeia.
  • Research and Development: The R & D team of Shandong High Chem - Pharm Co., Ltd. is constantly working on improving the formulation of tulathromycin. They are exploring new dosage forms, such as long - acting injectable formulations, to provide more convenient treatment options for farmers.
  • Cost - effectiveness: With its large - scale production and efficient management, the company can offer tulathromycin at a competitive price without sacrificing quality. This makes it an attractive choice for both large - scale livestock farms and small - to - medium - sized farmers.
  • Technical Support: The company provides comprehensive technical support to its customers. Its professional veterinarians can offer advice on the proper use of tulathromycin, dosage determination, and disease prevention strategies.
  • Website: For more information about the company and its tulathromycin products, please visit https://www.hchengbio.com/.


2. Zoetis Inc.

Company Introduction

Zoetis Inc. is a global leader in animal health, with a rich history and a strong presence in the veterinary pharmaceutical market. It was spun off from Pfizer in 2013 and has since continued to expand its product portfolio and global reach. Zoetis operates in more than 100 countries and has a diverse range of products for livestock, companion animals, and aquaculture.


The company invests heavily in research and development, with state - of - the - art R & D facilities around the world. Its R & D efforts focus on developing innovative solutions to address the most pressing health challenges in the animal kingdom. Zoetis also has a large sales and marketing team that works closely with veterinarians, farmers, and pet owners to ensure the proper use of its products.


Tulathromycin - related Features and Company Advantages

  • Extensive Research: Zoetis has conducted in - depth research on tulathromycin. It has carried out numerous clinical trials to evaluate the efficacy and safety of the product in different animal species and under various disease conditions. This research has led to a better understanding of the drug's mechanism of action and optimal usage.
  • Global Distribution Network: With its vast global distribution network, Zoetis can ensure the timely supply of tulathromycin to customers around the world. This is crucial for the livestock industry, where quick access to effective medications can prevent the spread of diseases and reduce economic losses.
  • Brand Reputation: Zoetis is a well - known and trusted brand in the animal health industry. Its tulathromycin products are associated with high quality, reliability, and innovation. Farmers and veterinarians have confidence in the effectiveness of Zoetis' tulathromycin, which is an important factor in the product's success.
  • Integrated Solutions: In addition to tulathromycin, Zoetis offers a comprehensive range of animal health products and services. It can provide integrated solutions for disease prevention and management, including vaccination programs, nutritional supplements, and diagnostic tools. This allows farmers to address multiple aspects of animal health with a single partner.


3. Merck Animal Health

Company Introduction

Merck Animal Health, a division of Merck & Co., Inc., is a major player in the animal health market. It has a long - standing commitment to improving animal health and well - being. The company has a wide range of products for livestock, companion animals, and wildlife, including vaccines, pharmaceuticals, and parasiticides.


Merck Animal Health has a global research and development network, with scientists working on cutting - edge technologies and therapies. It also has a strong focus on sustainability, aiming to reduce its environmental impact while providing high - quality products. The company collaborates with universities, research institutions, and other industry partners to drive innovation in animal health.


Tulathromycin - related Features and Company Advantages

  • Research and Innovation: Merck Animal Health invests significantly in research to improve the performance of tulathromycin. It is exploring new ways to enhance the drug's bioavailability and reduce potential side effects. The company's research efforts also focus on developing combination therapies that can provide more comprehensive protection against respiratory diseases in animals.
  • Regulatory Expertise: With its long - term experience in the pharmaceutical industry, Merck Animal Health has in - depth knowledge of global regulatory requirements. It ensures that its tulathromycin products meet all the necessary regulatory standards in different countries, which facilitates the smooth distribution and use of the product in the international market.
  • Customer Education: The company places great emphasis on customer education. It provides training programs for veterinarians and farmers on the proper use of tulathromycin, including dosage calculation, administration methods, and storage conditions. This helps to ensure the safe and effective use of the product.
  • Sustainable Practices: Merck Animal Health is committed to sustainable development in its production and business operations. It uses environmentally friendly manufacturing processes and packaging materials for its tulathromycin products, which is in line with the growing demand for sustainable products in the market.


4. Elanco Animal Health

Company Introduction

Elanco Animal Health is a global animal health company that has been serving the industry for many years. It offers a diverse portfolio of products, including pharmaceuticals, vaccines, and feed additives. The company has a strong presence in both developed and emerging markets, with a focus on providing innovative solutions to meet the evolving needs of the animal health sector.


Elanco Animal Health has a team of dedicated scientists, veterinarians, and business professionals. It invests in research and development to bring new and improved products to the market. The company also has a customer - centric approach, working closely with farmers, veterinarians, and other stakeholders to understand their needs and provide tailored solutions.


Tulathromycin - related Features and Company Advantages

  • Product Portfolio Complementarity: Elanco's tulathromycin products can be integrated with its other animal health products, such as vaccines and nutritional supplements. This allows for a more comprehensive approach to disease prevention and treatment in livestock. For example, combining tulathromycin with a suitable vaccine can provide better protection against respiratory diseases.
  • Field Experience: The company has extensive field experience in the use of tulathromycin. Its technical support team has worked with farmers in different regions, dealing with various disease situations. This experience enables them to provide practical advice on the use of tulathromycin in real - world scenarios.
  • Data - driven Approach: Elanco uses data analytics to improve the performance of its tulathromycin products. It collects and analyzes data from clinical trials, field studies, and customer feedback to optimize the product formulation, dosage, and administration methods. This data - driven approach helps to ensure the effectiveness and safety of the product.
  • Global Reach and Local Support: Elanco has a global presence, but it also provides local support to its customers. It has local offices and representatives in many countries, who can offer on - the - ground assistance, including product training, technical advice, and after - sales service.


5. Boehringer Ingelheim Animal Health

Company Introduction

Boehringer Ingelheim Animal Health is a well - established company in the animal health industry. It is part of the Boehringer Ingelheim Group, a global pharmaceutical and chemical company. The company offers a wide range of products for livestock, companion animals, and equines, including antibiotics, vaccines, and anti - parasitic agents.


Boehringer Ingelheim Animal Health has a strong R & D focus, with a large number of scientists working on developing new and improved animal health solutions. It also has a commitment to animal welfare and sustainable development. The company collaborates with international organizations and research institutions to address global animal health challenges.


Tulathromycin - related Features and Company Advantages

  • Multidisciplinary R & D Approach: The R & D team at Boehringer Ingelheim Animal Health uses a multidisciplinary approach to develop tulathromycin products. It combines the expertise of chemists, pharmacologists, veterinarians, and microbiologists to optimize the drug's properties and performance. This approach has led to the development of more effective and safer tulathromycin formulations.
  • Clinical Trials and Evidence - based Medicine: The company conducts extensive clinical trials to support the use of tulathromycin. It follows strict scientific protocols to generate high - quality evidence on the drug's efficacy and safety. This evidence - based approach helps veterinarians and farmers make informed decisions about the use of tulathromycin in animal health management.
  • Animal Welfare Focus: Boehringer Ingelheim Animal Health places a high priority on animal welfare. Its tulathromycin products are designed to not only treat diseases but also minimize the stress and discomfort of animals during the treatment process. For example, the company has developed easy - to - administer formulations that reduce the pain and anxiety associated with drug administration.
  • Global Partnerships: The company has established global partnerships with other industry players, research institutions, and non - profit organizations. These partnerships help to expand the knowledge base on tulathromycin and promote its proper use in different regions of the world.


6. Virbac

Company Introduction

Virbac is a family - owned company that specializes in animal health. It has a wide range of products for companion animals, livestock, and horses, including pharmaceuticals, vaccines, and dermatological products. The company has a strong focus on innovation, with a research and development center that is constantly working on new product concepts.


Virbac has a global presence, with subsidiaries and distribution partners in many countries. It is committed to providing high - quality products and services to its customers, and it places a great emphasis on customer satisfaction. The company also has a social responsibility program, aiming to contribute to the well - being of animals and the communities in which it operates.


Tulathromycin - related Features and Company Advantages

  • Niche Market Focus: Virbac has a unique approach to the market, often targeting niche segments within the animal health industry. Its tulathromycin products are designed to meet the specific needs of certain animal species or disease conditions. This allows the company to provide more tailored solutions and gain a competitive edge in the market.
  • Customer - Centric Innovation: The company's innovation is driven by customer needs. It conducts market research to understand the pain points of farmers and veterinarians when it comes to using tulathromycin, and then develops products and services to address these issues. For example, it may develop user - friendly packaging or dosing devices for tulathromycin products.
  • Quality Control and Traceability: Virbac has a strict quality control system in place for its tulathromycin production. It ensures that every batch of the product is thoroughly tested and meets the highest quality standards. The company also has a traceability system that allows it to track the origin and movement of the product from raw material sourcing to final delivery, which provides an extra layer of assurance for customers.
  • Educational Initiatives: Virbac organizes educational initiatives for veterinarians and farmers, focusing on the proper use of tulathromycin. These initiatives include seminars, workshops, and online resources, which help to improve the knowledge and skills of the end - users and promote the rational use of the product.


7. Hipra

Company Introduction

Hipra is a Spanish company that has made significant contributions to the animal health industry. It is a leading manufacturer of vaccines, pharmaceuticals, and diagnostic products for livestock and companion animals. The company has a strong research and development department, with a focus on developing innovative solutions to prevent and control animal diseases.


Hipra has a global distribution network, and its products are sold in more than 100 countries. The company is committed to quality, innovation, and sustainability. It invests in modern production facilities and quality control systems to ensure the high - quality of its products.


Tulathromycin - related Features and Company Advantages

  • Vaccine - Pharmaceutical Synergy: Hipra has the ability to combine its vaccine expertise with its tulathromycin products. This synergy allows for a more comprehensive approach to disease prevention and control in animals. For example, the company can develop vaccination programs that are complemented by the use of tulathromycin for post - vaccination protection against secondary infections.
  • Local Adaptation: Hipra understands the importance of local adaptation in the animal health market. It tailors its tulathromycin products and marketing strategies to meet the specific needs and regulatory requirements of different countries and regions. This ensures that the product is well - received and effectively used in local markets.
  • Research and Development Collaboration: The company collaborates with international research institutions and universities to conduct research on tulathromycin. These collaborations help to expand the knowledge base on the drug and drive innovation in its formulation and application.
  • Sustainable Production: Hipra is committed to sustainable production practices. It uses renewable energy sources in its manufacturing facilities and implements waste reduction and recycling programs. This makes its tulathromycin products more environmentally friendly and in line with the growing demand for sustainable products in the market.


8. Ceva Santé Animale

Company Introduction

Ceva Santé Animale is a global animal health company that offers a wide range of products and services for livestock, companion animals, and wildlife. It has a long - standing history of innovation and a strong commitment to animal health. The company has a global research and development network, with scientists working on developing new and improved animal health solutions.


Ceva Santé Animale has a customer - focused approach, aiming to provide high - quality products and excellent customer service. It also has a social responsibility program, which includes initiatives to support animal welfare and rural development.


Tulathromycin - related Features and Company Advantages

  • Comprehensive Product Range: In addition to tulathromycin, Ceva Santé Animale offers a comprehensive range of animal health products. This allows farmers and veterinarians to source multiple products from a single supplier, which simplifies the procurement process and ensures compatibility between different products.
  • Research and Development Excellence: The company's research and development team is dedicated to improving the performance of tulathromycin. It uses advanced technologies and scientific methods to optimize the drug's formulation, pharmacokinetics, and antibacterial activity. This research has led to the development of more effective and efficient tulathromycin products.
  • Global Technical Support: Ceva Santé Animale provides global technical support to its customers. Its team of veterinarians and technical experts can offer advice on the use of tulathromycin in different animal species and disease situations. This support helps to ensure the proper use of the product and maximize its therapeutic benefits.
  • Market Intelligence and Strategy: The company has a strong market intelligence team that monitors the global animal health market. It uses this information to develop effective marketing strategies for its tulathromycin products, ensuring that they are well - positioned in the market and meet the changing needs of customers.


9. Vetoquinol

Company Introduction

Vetoquinol is a French company that specializes in animal health products. It has a wide range of products for companion animals, livestock, and horses, including pharmaceuticals, nutraceuticals, and hygiene products. The company has a strong focus on research and development, with a team of scientists working on new product concepts and technologies.


Vetoquinol has a global presence, with subsidiaries and distribution partners in many countries. It is committed to providing high - quality products and services that meet the needs of its customers. The company also has a sustainable development strategy, aiming to reduce its environmental impact and contribute to the well - being of animals and society.


Tulathromycin - related Features and Company Advantages

  • Nutraceutical - Pharmaceutical Integration: Vetoquinol has the ability to integrate its nutraceutical products with tulathromycin. This integration can provide a more holistic approach to animal health, as nutraceuticals can support the immune system of animals, enhancing the effectiveness of tulathromycin in treating diseases.
  • Customized Solutions: The company offers customized solutions for its customers. It can develop tulathromycin products with specific formulations and dosages based on the unique requirements of different animal farms or veterinary clinics. This personalized approach helps to improve the treatment outcomes and customer satisfaction.
  • Research and Development in Emerging Markets: Vetoquinol conducts research and development activities in emerging markets, taking into account the specific disease patterns and economic conditions in these regions. This allows the company to develop more affordable and accessible tulathromycin products for farmers in emerging economies.
  • Environmental and Social Responsibility: Vetoquinol is committed to environmental and social responsibility. It uses sustainable packaging materials for its tulathromycin products and supports local communities through various social initiatives. This positive corporate image helps to build trust and loyalty among customers.


10. Biovet S.A.

Company Introduction

Biovet S.A. is a Romanian company that has been active in the animal health industry for many years. It produces a variety of veterinary products, including antibiotics, vaccines, and feed additives. The company has a modern production facility and a quality control system that meets international standards.


Biovet S.A. has a focus on research and development, aiming to develop new and improved products for the animal health market. It also has a strong distribution network in Europe and other regions, allowing it to reach a wide range of customers.


Tulathromycin - related Features and Company Advantages

  • Cost - Competitive Products: Biovet S.A. is able to offer tulathromycin products at a relatively low cost. This is due to its efficient production processes and cost - management strategies. The cost - competitiveness of its products makes them an attractive option for farmers, especially in price - sensitive markets.
  • Local Market Knowledge: The company has in - depth knowledge of the local markets in Europe and other regions where it operates. It understands the specific needs and preferences of local farmers and veterinarians, and can tailor its tulathromycin products and marketing strategies accordingly. This local market knowledge gives the company a competitive edge in the market.
  • Continuous Improvement: Biovet S.A. is committed to continuous improvement in its production and product quality. It invests in new technologies and equipment to optimize the manufacturing process of tulathromycin, and conducts regular quality audits to ensure the consistency and reliability of the product.
  • Technical Support in Local Languages: The company provides technical support in local languages, which is very convenient for farmers and veterinarians. This helps to overcome language barriers and ensures that the end - users can fully understand the instructions and advice regarding the use of tulathromycin.


Conclusion

The above - mentioned 10 companies are the best tulathromycin manufacturers in the world in 2025. Each company has its own unique strengths and advantages in terms of research and development, production, marketing, and customer service. Shandong High Chem - Pharm Co., Ltd. offers cost - effective and high - quality products with strong technical support. Zoetis, Merck Animal Health, and Elanco Animal Health are global giants with extensive research capabilities, wide distribution networks, and well - established brand reputations. Boehringer Ingelheim Animal Health, Virbac, Hipra, Ceva Santé Animale, Vetoquinol, and Biovet S.A. also have their own competitive edges, such as niche market focus, vaccine - pharmaceutical synergy, and cost - competitiveness.


In the future, as the demand for animal health products continues to grow, these companies will likely face new challenges and opportunities. They will need to continue to invest in research and development to improve the performance of tulathromycin, adapt to changing regulatory requirements, and meet the diverse needs of customers around the world. By leveraging their respective strengths and collaborating with each other and other industry stakeholders, they can contribute to the sustainable development of the animal health industry and the well - being of animals globally.


Send Inquiry